Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Global Cord Blood Corp (CO)

$6.32 0.13 (2.02%)

16:02 EDT CO Stock Quote Delayed 15 Minutes

Volume:

Previous Close $6.32

Market Cap 762.22M

PE Ratio 2.77

EPS 2.28

Volume (Avg. Vol.) 166,400

Day's Range 6.14 - 6.48

52-Week Range 5.67 - 10.12

Dividend & Yield 0.08 (1.27%)

CO Stock Predictions, Articles, and Global Cord Blood Corp News

From the Web

Oversold Conditions For Global Cord Blood (CO)

From Market News Video May 13, 2019

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

Global Cord Blood Breaks Below 200-Day Moving Average - Notable for CO

From Market News Video Apr 17, 2019

In trading on Wednesday, shares of Global Cord Blood Corp (CO) crossed below their 200 day moving average of $6.88, changing hands as low as $6.86 per share. Global Cord Blood Corp shares are currently trading down about 1.7% on the day..

The Exact Trigger that Indicates Volatility in FEDNAT HOLDING CO

From Capital Market Laboratories Mar 26, 2019

The Trigger That Turned FEDNAT HOLDING CO (NASDAQ:FNHC) Volatility into a Winner.

CO Crosses Above Key Moving Average Level

From Market News Video Mar 19, 2019

In trading on Tuesday, shares of Global Cord Blood Corp (CO) crossed above their 200 day moving average of $7.14, changing hands as high as $7.24 per share. Global Cord Blood Corp shares are currently trading up about 1.9% on the day..

CO Makes Bullish Cross Above Critical Moving Average

From Market News Video Feb 26, 2019

In trading on Tuesday, shares of Global Cord Blood Corp (CO) crossed above their 200 day moving average of $7.32, changing hands as high as $7.57 per share. Global Cord Blood Corp shares are currently trading up about 4.8% on the day..

The Daily Biotech Pulse: Immunomedics CEO Departs, Ultragenyx Offering, Karyopharm Awaits FDA Panel Vote

From Benzinga Feb 26, 2019

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Feb. 25) Abbott Laboratories (...

Navellier Ratings

Powered by Portfolio Grader

Total Grade

D

Sell

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!